nice vitamin d
TRANSCRIPT
-
8/10/2019 NICE Vitamin D
1/53
Vitamin D: increasing supplementuse among at-risk groups
!I: &J 2014
NICE public health guidance 56I...I/
-
8/10/2019 NICE Vitamin D
2/53
Contents
-
8/10/2019 NICE Vitamin D
3/53
@ H .......................................................................................................................................... 19
# H JH D I@H ................................................................................... 20
K H H JH D I@H.......................................................................................................... 21
4 CH .......................................................................................................................... 22
BI ............................................................................................................................................ 22
CIH...................................................................................................................................... 23
AJ@@HM JH D I@H...................................................................................................... 23
EJ.................................................................................................................................................. 24
@H
-
8/10/2019 NICE Vitamin D
4/53
8 * ................................................................................................................................ 37
9 IM H
-
8/10/2019 NICE Vitamin D
5/53
What is this guideline about?
Introduction
-
8/10/2019 NICE Vitamin D
6/53
Clinical judgement
C@@ >IH K@@ H H K
-
8/10/2019 NICE Vitamin D
7/53
1 Recommendations
-
8/10/2019 NICE Vitamin D
8/53
EI IHI I@HJH I@H H @I H
-
8/10/2019 NICE Vitamin D
9/53
$H @ K K
-
8/10/2019 NICE Vitamin D
10/53
EH@
-
8/10/2019 NICE Vitamin D
11/53
H I H@ H , H HIH @H
-
8/10/2019 NICE Vitamin D
12/53
@@ HH
-
8/10/2019 NICE Vitamin D
13/53
-
8/10/2019 NICE Vitamin D
14/53
K KH< @@ HH, @ @ H H@ H@
@@ IH H I H IH JH D I@HI@@M H.
-
8/10/2019 NICE Vitamin D
15/53
2 Who should take action?
Introduction
-
8/10/2019 NICE Vitamin D
16/53
Who should take action in detail
Recommendation 1
DHH @H
-
8/10/2019 NICE Vitamin D
17/53
Recommendation 9
I@ @H< E@; @H< EIH E@; @@ I;
-
8/10/2019 NICE Vitamin D
18/53
3 Context
Background
H D H@ @H@ KH<
-
8/10/2019 NICE Vitamin D
19/53
H
-
8/10/2019 NICE Vitamin D
20/53
&H@ DH &IHH IJM IH H
-
8/10/2019 NICE Vitamin D
21/53
@ H H H
-
8/10/2019 NICE Vitamin D
22/53
4 Considerations
-
8/10/2019 NICE Vitamin D
23/53
Communications
4.3 AJ H
-
8/10/2019 NICE Vitamin D
24/53
H
-
8/10/2019 NICE Vitamin D
25/53
H@ @@ @J@. K @ K H
-
8/10/2019 NICE Vitamin D
26/53
4.13
-
8/10/2019 NICE Vitamin D
27/53
BI H
-
8/10/2019 NICE Vitamin D
28/53
4.20 A @HH H
-
8/10/2019 NICE Vitamin D
29/53
5 Recommendations for research
-
8/10/2019 NICE Vitamin D
30/53
5.3 K I@HM < H J K, J@@HM
IH JH D I@H H H@
-
8/10/2019 NICE Vitamin D
31/53
6 Related NICE guidance
Published
F@@: H JH @@ @ @ &!CE I@ CG161 (2013).
B
-
8/10/2019 NICE Vitamin D
32/53
7 Glossary
At-risk groups
I@H I H
-
8/10/2019 NICE Vitamin D
33/53
IHM I H J K , H, HJH.
F L@, H
-
8/10/2019 NICE Vitamin D
34/53
J
-
8/10/2019 NICE Vitamin D
35/53
Low vitamin D status
$K JH D HHI (H @@ JH D M) M H
-
8/10/2019 NICE Vitamin D
36/53
Vegan
@ K
-
8/10/2019 NICE Vitamin D
37/53
8 References
" , C A, H @. (2013)A I@HHJ HIM IH JH
E@. A
-
8/10/2019 NICE Vitamin D
38/53
9 Summary of the methods used to develop this guideline
Introduction
-
8/10/2019 NICE Vitamin D
39/53
1. K HJ H HJ HJH H K @HH
LH I JH D
-
8/10/2019 NICE Vitamin D
40/53
< H K
@@ J I M &!CE < 2013.
Selection criteria
HI K @I H
-
8/10/2019 NICE Vitamin D
41/53
Quality appraisal
!@I K H
-
8/10/2019 NICE Vitamin D
42/53
Economic modelling
A @ K HIH, H H H
-
8/10/2019 NICE Vitamin D
43/53
E @HH M HH
-
8/10/2019 NICE Vitamin D
44/53
10 The evidence
Introduction
-
8/10/2019 NICE Vitamin D
45/53
Recommendation 7: J HHH 1.7; E; !DE
Recommendation 8: J HHH 1.10, 1.11, 2.2, 2.9
Recommendation 9: J HHH 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.10, 1.11, 2.3, 2.4, 2.5,
2.13
Recommendation 10: J HHH 1.10, 1.11, 1.12, 2.14
Recommendation 11: J HHH 2.6; !DE
Economic modelling
-
8/10/2019 NICE Vitamin D
46/53
11 Gaps in the evidence
-
8/10/2019 NICE Vitamin D
47/53
12 Membership of the Public Health Advisory Committee
and the NICE project team
Public Health Advisory Committee A
&!CE
-
8/10/2019 NICE Vitamin D
48/53
Lucy Yardley
@H< M
-
8/10/2019 NICE Vitamin D
49/53
Caroline Mulvihill
A@MH
Alastair Fischer
H (I H "I 2014)
Rupert Franklin
>H ( "I 2014)
Rukshana Begum
CH
Sue Jelley
EH
Susie Burlace
EH
H D: I@H I H- I &!CE I@
-
8/10/2019 NICE Vitamin D
50/53
About this guideline
What does this guideline cover?
-
8/10/2019 NICE Vitamin D
51/53
F H
-
8/10/2019 NICE Vitamin D
52/53
H H
-
8/10/2019 NICE Vitamin D
53/53
&!CE